Concord Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 217.67 | 439.27 | 258.95 |
| Operating Expense | 142.59 | 239.46 | 146.27 |
| Net Profit | 42.57 | 141.94 | 74.09 |
| Net Profit Margin | 19.56 | 32.31 | 28.61 |
| Earning Per Share | 4.07 | 13.57 | 7.08 |
| EBIDTA | 74.49 | 198.48 | 111.14 |
| Effective Tax Rate | 18.76 | 20.93 | 21.02 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 217.67 |
| Operating Expense | 142.59 |
| Net Profit | 42.57 |
| Net Profit Margin | 19.56 |
| Earning Per Share | 4.07 |
| EBIDTA | 74.49 |
| Effective Tax Rate | 18.76 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,200.09 | 1,016.94 | 853.17 |
| Operating Expenses Annual | 693.76 | 585.38 | 509.88 |
| Operating Profit Annual | 550.78 | 465.34 | 378.60 |
| Interest Annual | 0.53 | 2.55 | 4.51 |
| Depreciation | 52.31 | 51.56 | 49.54 |
| Net Profit Annual | 372.96 | 304.73 | 238.13 |
| Tax Annual | 122.91 | 104.46 | 81.93 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,200.09 |
| Operating Expenses Annual | 693.76 |
| Operating Profit Annual | 550.78 |
| Interest Annual | 0.53 |
| Depreciation | 52.31 |
| Net Profit Annual | 372.96 |
| Tax Annual | 122.91 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 15.14 | 3.50 | 0.67 |
| Cash Flow from Operations | 244.52 | 265.47 | 246 |
| Cash Flow from Investing | -159.99 | -154.61 | -157.95 |
| Cash Flow from Financing | -98.77 | -99.21 | -85.22 |
| Cash Flow at the End | 0.90 | 15.14 | 3.50 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 15.14 |
| Cash Flow from Operations | 244.52 |
| Cash Flow from Investing | -159.99 |
| Cash Flow from Financing | -98.77 |
| Cash Flow at the End | 0.90 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 45.94 | 45.82 | 44.45 |
| PBIT Margin (%) | 41.41 | 40.55 | 38.12 |
| PBT Margin (%) | 1.60 | 27.80 | 30.76 |
| Net PROFIT Margin (%) | 31.08 | 29.97 | 27.91 |
| Return On Networth / Equity (%) | 22.35 | 21.63 | 19.85 |
| Return On Networth /Employed (%) | 29.62 | 28.81 | 26.05 |
| Return On Assets (%) | 22.38 | 21.28 | 18.98 |
| Total Debt / Equity (X) | TBA | 0.01 | 0.04 |
| Asset Turnover Ratio (%) | 0.72 | 0.71 | 0.68 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 45.94 |
| PBIT Margin (%) | 41.41 |
| PBT Margin (%) | 1.60 |
| Net PROFIT Margin (%) | 31.08 |
| Return On Networth / Equity (%) | 22.35 |
| Return On Networth /Employed (%) | 29.62 |
| Return On Assets (%) | 22.38 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 795.21 | 575.32 | 592.98 |
| Total Current Assets Annual | 1,135.24 | 896.23 | 727.70 |
| Non Current Assets Annual | 898.94 | 803.08 | 786.95 |
| Total Shareholders Funds Annual | 1,812.65 | 1,525.25 | 1,291.98 |
| Total Assets Annual | 2,034.18 | 1,699.32 | 1,514.65 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 795.21 |
| Total Current Assets Annual | 1,135.24 |
| Non Current Assets Annual | 898.94 |
| Total Shareholders Funds Annual | 1,812.65 |
| Total Assets Annual | 2,034.18 |
EPS (INR)
Expected
4.21
Reported
4.21
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
